Results 151 to 160 of about 70,291 (259)

Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024

Addiction, EarlyView.
Abstract Background and aims Nitazenes are a novel subclass of synthetic opioids that have been increasingly implicated in the United States (US) overdose crisis. Despite their growing presence in the illicit drug supply, national trends have not been systematically evaluated.
David T. Zhu, Nicole D. Fitzgerald, Joseph J. Palamar, Alex J. Krotulski   +3 more
wiley   +1 more source

A two-factor structure for cannabis use disorder identification test and its associations with demographic factors and cannabis use motives. [PDF]

Adv Drug Alcohol Res
Heckel N, Nordt C, Engeli EJE, Dürler P, Herdener M.   +4 more
europepmc   +1 more source

Proportions and correlates of high‐risk cannabis use in Australia—A cross‐sectional analysis of the 2022–2023 National Drug Strategy Household Survey

Addiction, EarlyView.
Abstract Background and aim Cannabis use is prevalent in Australia, however, limited research has explored the levels of high‐risk cannabis use within nationally representative samples. This study aimed to address this gap by examining the proportion of individuals meeting criteria for high‐risk cannabis use and identifying its correlates in a ...
Janni Leung, Daniel Stjepanović, Gary Chung Kai Chan, Wayne Denis Hall, Danielle Dawson   +4 more
wiley   +1 more source

Prevalence, Associations and Comorbidity of Cannabis Use and Cannabis Use Disorders in the Australian National Mental Health Surveys From 2007 to 2020-22. [PDF]

Drug Alcohol Rev
Wilson J, Sunderland M, O'Dean S, Slade T, Dawson D, Dobson O, Leung J, Chan G, Teesson M, Hall W, Newton N, Lorenzetti V, Stockings E.   +12 more
europepmc   +1 more source

A call for action: Closing the evidence gap in management of stimulant‐induced psychosis

Addiction, EarlyView.
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier, Heidar Sharafi, Adam Bisaga, Didier Jutras‐Aswad   +3 more
wiley   +1 more source

Sex and gender influences on problematic cannabis use and cannabis use disorder: A scoping review protocol. [PDF]

PLoS One
Matheson J, Mielnik CA, Knight R, Wright M, Marley N, Bonato S, Le Foll B, Gallagher L, Rubin-Kahana DS.   +8 more
europepmc   +1 more source

High temporal resolution monitoring of illicit drug consumption across England via wastewater analysis

Addiction, EarlyView.
Abstract Aim To monitor community‐level consumption of 20 illicit drugs across urban areas of England using wastewater‐based epidemiology (WBE) surveillance at high temporal resolution. Design, setting, cases This study was conducted over a 12‐month period in 2022 sampling 24‐hour composite wastewater samples at 15 wastewater treatment plants (WWTPs ...
Helena Rapp‐Wright, Keng Tiong Ng, Derryn Grant, William Francis, Margarita White, Dimitris Evangelopoulos, Yuxing Liu, Konstantina Dimakopoulou, Sofia Zafeiratou, Dylan Wood, Chryshanthi Christy, Stav Friedman, Timothy W. Gant, Klea Katsouyanni, Leon P. Barron   +14 more
wiley   +1 more source

Elevated Stress Reactivity: A Barrier to Cannabis Use Change Behavior. [PDF]

Subst Use Misuse
Cannon MJ, Schermitzler BS, Le V, Afshar K, Preston TJ, Macatee RJ.   +5 more
europepmc   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

Mobile intervention for emerging adults with regular cannabis use: a micro-randomized trial. [PDF]

Lancet Reg Health Am
Walton M, Nahum-Shani I, Campbell M, Tomlinson DC, Florimbio AR, Ghosh S, Guo Y, Hung PY, Newman MW, Lin JJ, Qian T, Dziak J, Pan H, Zhang KW, Zimmermann L, Bonar EE, Murphy S, Coughlin LN.   +17 more
europepmc   +1 more source